Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e655–e660. doi: 10.1016/j.ijrobp.2012.01.061

Table 1.

Patient and treatment characteristics.

ALL
PATIENTS
NO(%)
PATIENTS
WITHOUT
NECROSIS
NO(%)
PATIENTS
WITH
NECROSIS
NO(%)

SEX
Female 87 (36.86) 83 (36.40) 4 (50)

Male 149 (63.13) 145 (61.44) 4 (50)

RACE
Asian 5 (2.12) 5 (2.19) 0

Asian and White 1 (0.42) 1 (0.44) 0

Black 34 (14.41) 30 (13.16) 4 (50)

Black and White 1 (0.42) 1 (0.44) 0

Multiple Race
(NOS)
1 (0.42) 1 (0.44) 0

Other 14 (5.93) 14 (6.14) 0

White 180 (76.27) 176 (77.19) 4 (50)

DIAGNOSIS
Medulloblastoma
186 (78.81) 179 (78.51) 7 (87.50)
AT/RT
24 (10.17) 23 (10.09 1 (12.50)
SPNET
19 (8.05) 19 (8.33) 0
Pineoblastoma
7 (2.97) 7 (3.07) 0
RISK GROUP
Average-Risk 148 (62.71) 144 (63.16) 4 (50)

High-Risk 88 (37.29) 84 (36.84) 4 (50)

LOCATION
Infratentorial 195 (82.63) 187 (82.02) 8 (100)

Spinal cord 3 (1.27) 3 (1.32) 0

Supratentorial 38 (16.10) 38 (16.67) 0

EXTENT OF SURGERY

Biopsy 6 (2.54) 6 (2.63) 0

STR 24 (10.17) 23 (10.09) 1 (12.50)

NTR 40 (16.95) 39 (17.11) 1 (12.50)

GTR 166 (70.34) 160 (70.18) 6 (75.00)

NUMBER OF
RESECTIONS

1 181 (76.69) 175 (76.75) 6 (75.00)

>1 55 (23.31) 53 (23.25) 2 (25.00)

TOTAL 236 228 8